Clinical trial
Ketamine Enhancement of rTMS for Refractory Depression
NCT04352621 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ketamine Enhancement of rTMS for Refractory Depression
- Lead sponsor
- University of Cincinnati
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 1, 2020
- Completion date
- May 1, 2022
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.